These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16810057)

  • 1. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
    Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
    Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
    Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
    Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
    Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma.
    Levine RL; Cargile CB; Blazes MS; van Rees B; Kurman RJ; Ellenson LH
    Cancer Res; 1998 Aug; 58(15):3254-8. PubMed ID: 9699651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microsatellite instability and loss of heterozygosity in neoplastic and preneoplastic gastric lesions].
    Roa JC; Araya JC; Villaseca MA; Roa I; Correa P
    Rev Med Chil; 2003 Nov; 131(11):1227-36. PubMed ID: 14743682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.
    Takamochi K; Ogura T; Suzuki K; Kawasaki H; Kurashima Y; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Esumi H
    Am J Pathol; 2001 Nov; 159(5):1941-8. PubMed ID: 11696455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
    Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
    Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
    Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survival.
    Huan Z; Nakayama K; Nakayama N; Ishibashi M; Yeasmin S; Katagiri A; Purwana IN; Iida K; Maruyama R; Fukumoto M; Miyazaki K
    Oncol Rep; 2008 Mar; 19(3):775-81. PubMed ID: 18288415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss studies do not provide evidence for the "endometriosis-as-tumor" theory.
    Prowse AH; Fakis G; Manek S; Churchman M; Edwards S; Rowan A; Koninckx P; Kennedy S; Tomlinson IP
    Fertil Steril; 2005 Apr; 83 Suppl 1():1134-43. PubMed ID: 15831286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H; Li Z; Chen M; Zhang G; Xu K
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.